On behalf of the entire SHSA 2021 planning committee, we hope you will join us online, September 24-26, 2021 for our 6th Annual Symposium on Hidradenitis Suppurativa Advances meeting co-hosted by the Canadian Hidradenitis Suppurativa Foundation (CHSF) and the Hidradenitis Suppurativa Foundation (HSF).
We are planning an extraordinary weekend of live online virtual interactions including; open panel discussions, guided oral & poster presentations with discussion, group breakout & chat rooms with leading experts and exhibit areas.
Our goal this year is to build on our momentum by exceeding the record number of participants at last year’s meeting (nearly four-hundred people)! We thank the national/ international speakers, researchers, clinicians, people affected by HS and our valued sponsors who helped make last year’s first ever virtual conference a huge success.
We plan to highlight current advances in Basic & Translational Science Research, Clinical Trial Design & Outcome Measures, Health Services Research & Epidemiology and expand discussion around HS research with an array of leading-edge guest speakers.
Isabelle Delorme, MD (Co-Chair)
Joslyn Kirby, MD, MS, MEd. (Co-Chair)
Isabelle Delorme, MD, President, Canadian Hidradenitis Suppurativa Foundation (CHSF) and Dermatologist, Dr. Isabelle Delorme Inc., Drummondville, QC, Canada
Joslyn S. Kirby, MD, MS, Med, Vice President, Hidradenitis Suppurativa Foundation (HSF), Associate Professor, Department of Dermatology, Pennsylvania State, Hershey, PA, USA
Afsaneh Alavi, MD, MSc, FRCPC, Associate Professor, Department of Dermatology, Mayo Clinic, Rochester, MN, USA
Raed Alhusayen, MBBS, MSCE, FRCPC, Associate Professor, University of Toronto, Associate Scientist, Sunnybrook Research Institute, Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Marc Bourcier, MD, FRCP, FAAD; Assistant Professor in clinical teaching faculty of Medicine, Sherbrooke University; Dermatologist, Moncton, New-Brunswick, Canada
Angel Byrd, MD, PhD, Asst. Professor, Howard University College of Medicine, Washington, DC, USA
Patricia Coutts, Registered Nurse at Toronto Wound Healing Centre, Toronto, ON, Canada
Steven Daveluy, MD, FAAD, Associate Professor and Program Director, Dept of Dermatology, Wayne State University, Detroit, MI, USA
Ralph George, MD, FRCS, Associate Professor, General Surgery, University of Toronto, Toronto, ON, Canada
Stephanie Goldberg, MD, Mary Washington Healthcare, Fredericksburg, VA, USA
Athena Mammis-Gierbolini, Patient Lead, Hope for HS, Hershey, PA, USA
Iltefat Hamzavi, MD, FAAD, President HSF, Dermatologist, Department of Dermatology, Henry Ford Hospital, Clinical Associate Professor Wayne State University and Hamzavi/Dermatology Specialists, Detroit, MI, USA
Paul Hazen, MD, Clinical Associate Professor, Case Western Reserve University; Dermatologist, HS Institute, Westlake, OH, USA
Brent Hazelett, Executive Director HS Foundation, Apex, NC, USA
Hadar Lev-Tov, MD, MAS, Assistant Professor, Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL, USA
Michelle Lowes, MB.BS, PhD, New York, NY, USA
Angela Parks-Miller, RN, CCRP, CWCA, Clinical Research Manager, Department of Dermatology, Henry Ford Health Systems, Founding Director, HS Foundation, Detroit, MI, USA
Elizabeth O'Brien, MD, Associate Professor, Internal Medicine, McGill University, Senior Staff, Dermatology, Montreal General Hospital, Montreal, QC, Canada
Vincent Piguet, MD, PhD, FRCP (London), Professor and Division Director, Dermatology, University of Toronto and Division Head, Dermatology, Women's College Hospital, Toronto, ON, Canada
Se Mang Wong, MD, FRCPC, Clinical Associate Professor, UBC Department of Dermatology and Skin Science, Vancouver, BC, Canada